A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.
about
Selective serotonin reuptake inhibitors for fibromyalgia syndromeBiology and therapy of fibromyalgia. New therapies in fibromyalgiaMajor depression, fibromyalgia and labour force participation: a population-based cross-sectional studyTreating Chronic Pain with SSRIs: What Do We Know?Immunomodulatory effects mediated by serotoninManagement of fibromyalgia syndrome: review of evidence.[Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].Fibromyalgia-: a review for the psychiatrist.OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysisAn update on pharmacotherapy for the treatment of fibromyalgia.Antidepressants in the treatment of fibromyalgia.Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms.Juvenile fibromyalgia: current status of research and future developments.The FIBRO System: A Rapid Strategy for Assessment and Management of Fibromyalgia SyndromeCharacteristics and healthcare costs of patients with fibromyalgia syndromeManagement strategies for fibromyalgiaThe art of prescribing. Depression and fibromyalgia syndrome (FMS): pharmacologic considerations.Serotonin-induced hypersensitivity via inhibition of catechol O-methyltransferase activityGuidelines for the use of antidepressants in painful rheumatic conditions.In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review.Delineating neck targets for intensity- modulated radiation therapy of head and neck cancer. What we learned from marginal recurrences?Fibromyalgia--management of a misunderstood disorder.Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome.Newer treatments for fibromyalgia syndrome.Treatment options and patient perspectives in the management of fibromyalgia: future trends.Fibromyalgia: harmonizing science with clinical practice considerations.Fibromyalgia: nosography and therapeutic perspectives.Genetic variation in the serotonin transporter gene (5-HTTLPR, rs25531) influences the analgesic response to the short acting opioid Remifentanil in humans.Advances in diagnostic and treatment options in patients with fibromyalgia syndromeBeyond pain in fibromyalgia: insights into the symptom of fatigue.Emerging therapies for fibromyalgia: an update.A review of SSRIs and SNRIs in neuropathic pain.Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists.Efficacy of antidepressants as analgesics: a review.Pain and depression: an integrative review of neurobiological and psychological factors.Fibromyalgia Pathogenesis and Treatment Options Update.Serotonin noradrenaline reuptake inhibitors: New hope for the treatment of chronic pain.An open-label clinical trial of milnacipran in fibromyalgia syndrome with co-morbid depressive symptoms.No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls.
P2860
Q24187263-CA7B8EE2-BBBB-4A34-9B04-3B55D289DC37Q24684137-71B1041F-8029-4FD0-A55C-C22BE56845BCQ25257907-65C51958-2BFC-46FA-9FD1-0BB49456F50AQ26738470-5A7C1897-8DEB-42C3-BFC0-C7893DD934B8Q28084203-B74018E9-D75B-45AD-A734-E32326F1223EQ33938302-753FD199-5D24-4DF9-80F4-2824A2F852B1Q34285830-2EE5A4DA-5D9A-409A-93B2-80976E8B5424Q34343947-EC510A49-3783-42F2-83F0-1C6F76D50CE2Q34459831-E27F5BA4-B900-4F29-A7D7-3469DA6B820DQ34477510-F747825B-2917-45BC-BDE0-9E19C96198B9Q34607230-E3763E38-D751-4A3D-9643-AC7504C81906Q34974870-101B5C41-8CFC-4316-B95A-B1C034CE70C8Q35228420-6514EBF9-F663-4973-9EF0-38DD323A7FAEQ35751360-027AE7C4-1BF5-4367-B42E-C43397B19195Q36059504-CC553BF8-7F75-4766-9ABB-06FD652EE2CEQ36088604-E2173688-C7C4-42C3-B112-43FC8016A132Q36176739-4D6ECE91-0D6B-4456-A357-2393B7AB842AQ36247338-F96799E5-3221-45AE-96A1-5411D208B888Q36391713-856CBF90-6F6D-4CAD-92F2-9BFAE3E9E9EAQ36402066-1C9947A4-62C2-41B3-883C-351E0E859B39Q36488214-6D6FA210-B855-4296-A43F-DC44637C58A0Q36887019-5973D3F4-00BF-4CCD-BF88-4D594B2F20EAQ36903055-B712D9C3-0B65-4048-B812-BABA2D98D0B4Q36955343-9ADDA9DB-630B-453D-9B89-6E5F24A0B825Q37098174-38F0E102-7598-4D24-9B26-1D3375A860A6Q37106939-7C75FAC6-41E4-4E62-80D8-00D3D2B4ABAAQ37117994-9C42ED76-394C-4C82-81B0-A83CED55EBAAQ37121816-0CDB22E5-8908-4B41-968E-6187D8802519Q37281305-7C8AAB3A-DB7B-46BE-A912-023CEC79749BQ37358110-3F17EBC6-EB9C-4638-8F8D-24DC9639E0BBQ37690090-B61224D5-BC17-4CA8-8E7B-BA204C540693Q37756999-333515B5-D727-483B-8C3B-E5268E22ECE9Q37773988-641548AD-E702-49BC-AA15-D4B870128DA1Q37842595-0986CDD7-B711-45F9-8F7C-D5B6332FA9B0Q37854293-A1EDE074-FBAA-4A82-A8E2-1FC5E8879328Q38161494-E6A818F7-012D-403C-AF6B-85585D796B53Q38753091-5CA5F4C9-F6DA-4980-B926-3CEAA0B915D3Q42665607-696148CF-B827-409C-BDA7-035CCFFC1168Q42666684-9F07819C-1B93-46E2-A703-E27D44EC542DQ43192003-1FE31D36-E647-4126-84AD-D9BB7D8405B8
P2860
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@en
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@nl
type
label
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@en
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@nl
prefLabel
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@en
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@nl
P2093
P1476
A randomized, placebo-controll ...... nt of women with fibromyalgia.
@en
P2093
James I Hudson
Jeffrey A Welge
Paul E Keck
Sarah E Berno
P304
P356
10.1016/S0002-9343(01)01089-0
P407
P577
2002-02-01T00:00:00Z